The Path to Eliminating Cervical Cancer in Canada: Past, Present and Future Directions.


Journal

Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503

Informations de publication

Date de publication:
14 02 2022
Historique:
received: 15 12 2021
revised: 30 01 2022
accepted: 08 02 2022
entrez: 24 2 2022
pubmed: 25 2 2022
medline: 25 3 2022
Statut: epublish

Résumé

Cervical cancer remains a common cancer affecting women in Canada. While cervical cancer incidence and mortality in Canada have declined for several decades due to the success of organized, provincial cervical cancer screening programs, further decreases will require enhancement of primary, secondary, and tertiary prevention efforts. The present commentary provides a historical overview of cervical cancer trends in Canada, presents current statistics on cervical cancer incidence, mortality and survival, and discusses future directions in relation to cervical cancer elimination.

Identifiants

pubmed: 35200594
pii: curroncol29020095
doi: 10.3390/curroncol29020095
pmc: PMC8870792
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1117-1122

Subventions

Organisme : CIHR
ID : FDN-143339
Pays : Canada

Références

JAMA. 2018 Jul 3;320(1):43-52
pubmed: 29971397
Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):641-52
pubmed: 23549400
J Obstet Gynaecol Can. 2019 Dec;41 Suppl 2:S177-S180
pubmed: 31785651
J Obstet Gynaecol Can. 2019 Jun;41(6):824-831.e1
pubmed: 30361160
J Obstet Gynaecol Can. 2018 Dec;40(12):1555-1557
pubmed: 30527069
CMAJ Open. 2021 Apr 22;9(2):E424-E432
pubmed: 33888548
CMAJ. 2007 Aug 28;177(5):480-3
pubmed: 17724326
CMAJ. 2019 Nov 18;191(46):E1262-E1273
pubmed: 31740536
Curr Oncol. 2021 Feb 22;28(1):991-1007
pubmed: 33617515
N Engl J Med. 2020 Oct 1;383(14):1340-1348
pubmed: 32997908
J Infect Dis. 2020 Jan 1;221(1):81-90
pubmed: 31504649
Can J Public Health. 2013 Feb 11;104(2):e159-66
pubmed: 23618210
J Pathol. 1999 Sep;189(1):12-9
pubmed: 10451482
CMAJ. 2020 Mar 2;192(9):E199-E205
pubmed: 32122974

Auteurs

Hannah Caird (H)

BC Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada.

Jonathan Simkin (J)

BC Cancer, Vancouver, BC V5Z 4E6, Canada.
Faculty of Medicine, School of Population and Public Health, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.

Laurie Smith (L)

BC Cancer, Vancouver, BC V5Z 4E6, Canada.
Women's Health Research Institute, Vancouver, BC V6H 2N9, Canada.

Dirk Van Niekerk (D)

BC Cancer, Vancouver, BC V5Z 4E6, Canada.
Faculty of Medicine, School of Population and Public Health, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.

Gina Ogilvie (G)

BC Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada.
BC Cancer, Vancouver, BC V5Z 4E6, Canada.
Faculty of Medicine, School of Population and Public Health, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Women's Health Research Institute, Vancouver, BC V6H 2N9, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH